Since mutations in RNA modification genes have been reported to be associated with several types of human cancers, the mutation analysis of PUS7 was performed in cBioPortal, demonstrating the fusion of PUS7 with SRSF Protein Kinase 2 (SRPK2) in serous ovarian cancer (Table 2). Here, SRPK2 is linked to cancer.